Israel Englander Eledon Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.54 - $2.13 $13,847 - $19,152	-8,992 Reduced 39.32%	13,875 $28,000
Q4 2023 Feb 14, 2024	SELL	$1.12 - $1.86 $22,551 - $37,451	-20,135 Reduced 46.82%	22,867 $41,000
Q2 2023 Aug 14, 2023	BUY	$1.34 - $2.85 $40,731 - $86,631	30,397 Added 241.15%	43,002 $58,000
Q1 2023 May 15, 2023	BUY	$2.0 - $3.46 $25,210 - $43,613	12,605 New	12,605 $30,000

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.